West Tower Group’s Bristol-Myers Squibb BMY Stock Holding History

West Tower Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-8,000	Closed	-$370K	–	50
2025 Q2	$370K	Buy	+8,000	New	+$393K	0.8%	46

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

West Tower Group's BMY Position: Q3 2025 in Review

West Tower Group sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 8,000 shares — an estimated $370K sold.

West Tower Group first reported a position in BMY in Q2 2025 and held it in 1 quarter. The position peaked at $370K in Q2 2025. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

West Tower Group reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
West Tower Group sold 8,000 Bristol-Myers Squibb shares in Q3 2025, an estimated $370K.
West Tower Group first reported a position in Bristol-Myers Squibb in Q2 2025 and held it in 1 quarter.
West Tower Group's Bristol-Myers Squibb position peaked at $370K in Q2 2025.
2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on West Tower Group's 13F filing for Q3 2025, filed 16 Oct 2025.